Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (121-130 of 303) with videos related to

Pageof 31
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2003
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphismsTatsuyoshi Kawamura, Forrest O Gulden, Makoto Sugaya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantationLeonard H Calabrese, Michael M Lederman, John Spritzler, et al.
Blood|April 17, 2013
Interleukin-7 promotes HIV persistence during antiretroviral therapyClaire Vandergeeten, Rémi Fromentin, Sandrina DaFonseca, et al.
Iscience|May 30, 2024
Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIVThomas A Premeaux, Scott Bowler, Courtney M Friday, et al.
AIDS (London, England)|September 26, 2014
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine studyJonathan Z Li, Andrea Heisey, Hayat Ahmed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2014
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapyNicholas T Funderburg, Ying Jiang, Sara M Debanne, et al.
AIDS (London, England)|September 20, 2013
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reductionRobert C Kalayjian, John Spritzler, Roy M Matining, et al.
The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.
The Journal of Infectious Diseases|April 1, 2009
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challengeRonald S Veazey, Binhua Ling, Linda C Green, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2015
Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover TrialChristophe Vanpouille, Andrea Lisco, Jean-Charles Grivel, et al.
Pageof 31

Showing results (121-130 of 303) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2003
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphismsTatsuyoshi Kawamura, Forrest O Gulden, Makoto Sugaya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantationLeonard H Calabrese, Michael M Lederman, John Spritzler, et al.
Blood|April 17, 2013
Interleukin-7 promotes HIV persistence during antiretroviral therapyClaire Vandergeeten, Rémi Fromentin, Sandrina DaFonseca, et al.
Iscience|May 30, 2024
Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIVThomas A Premeaux, Scott Bowler, Courtney M Friday, et al.
AIDS (London, England)|September 26, 2014
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine studyJonathan Z Li, Andrea Heisey, Hayat Ahmed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2014
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapyNicholas T Funderburg, Ying Jiang, Sara M Debanne, et al.
AIDS (London, England)|September 20, 2013
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reductionRobert C Kalayjian, John Spritzler, Roy M Matining, et al.
The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.
The Journal of Infectious Diseases|April 1, 2009
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challengeRonald S Veazey, Binhua Ling, Linda C Green, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2015
Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover TrialChristophe Vanpouille, Andrea Lisco, Jean-Charles Grivel, et al.
Pageof 31